118 related articles for article (PubMed ID: 2790330)
1. An immunotoxin system intended for bone marrow purging composed of glucose oxidase and lactoperoxidase coupled to monoclonal antibody 097.
Ito HO; Morizet J; Coulombel L; Goavec M; Rousseau V; Bernard A; Stanislawski M
Bone Marrow Transplant; 1989 Sep; 4(5):519-27. PubMed ID: 2790330
[TBL] [Abstract][Full Text] [Related]
2. T cell depletion of human bone marrow using an oxidase-peroxidase enzyme immunotoxin.
Ito H; Morizet J; Coulombel L; Stanislawski M
Bone Marrow Transplant; 1990 Dec; 6(6):395-8. PubMed ID: 2097007
[TBL] [Abstract][Full Text] [Related]
3. Anti-T cell immunotoxins containing pokeweed anti-viral protein: potential purging agents for human autologous bone marrow transplantation.
Ramakrishnan S; Uckun FM; Houston LL
J Immunol; 1985 Nov; 135(5):3616-22. PubMed ID: 3900212
[TBL] [Abstract][Full Text] [Related]
4. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
Siena S; Villa S; Bonadonna G; Bregni M; Gianni AM
Transplantation; 1987 Mar; 43(3):421-6. PubMed ID: 3103275
[TBL] [Abstract][Full Text] [Related]
5. Immunotoxins containing glucose oxidase and lactoperoxidase with tumoricidal properties: in vitro killing effectiveness in a mouse plasmacytoma cell model.
Stanislawski M; Rousseau V; Goavec M; Ito H
Cancer Res; 1989 Oct; 49(20):5497-504. PubMed ID: 2790777
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.
Kernan NA; Knowles RW; Burns MJ; Broxmeyer HE; Lu L; Lee HM; Kawahata RT; Scannon PJ; Dupont B
J Immunol; 1984 Jul; 133(1):137-46. PubMed ID: 6609971
[TBL] [Abstract][Full Text] [Related]
7. Preclinical studies on deoxycoformycin and deoxyadenosine as pharmacologic T cell purging tools.
Sheridan W; Gordon DS; Fullen AJ; Olson A; Vogler WR; Winton E
Bone Marrow Transplant; 1989 Sep; 4(5):511-7. PubMed ID: 2790329
[TBL] [Abstract][Full Text] [Related]
8. Cryopreservation of human bone marrow after purging T-cells or tumor cells.
Zhang ZX; Xu YJ; Chen Y; Li Y; Shen BF; Bai Y
Cryobiology; 1994 Oct; 31(5):478-82. PubMed ID: 7988157
[TBL] [Abstract][Full Text] [Related]
9. Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential.
Boswell HS; Wade PM; Quesenberry PJ
J Immunol; 1984 Dec; 133(6):2940-9. PubMed ID: 6149245
[TBL] [Abstract][Full Text] [Related]
10. T-cell depletion with ricin A-chain T101 in allogeneic bone marrow transplantation to prevent severe graft-versus-host disease.
Fauser AA; Shustik C; Langleben A; Laurent G; Kanz L; Spurll GM; Price G; Ahlgren PD; Cooper BA
Clin Invest Med; 1988 Feb; 11(1):40-6. PubMed ID: 3284672
[TBL] [Abstract][Full Text] [Related]
11. Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin.
Montgomery RB; Kurtzberg J; Rhinehardt-Clark A; Haleen A; Ramakrishnan S; Olsen GA; Peters WP; Smith CA; Haynes BF; Houston LL
Bone Marrow Transplant; 1990 Jun; 5(6):395-402. PubMed ID: 2369680
[TBL] [Abstract][Full Text] [Related]
12. Immunotoxin depletion of T cells and its effect on hematopoietic progenitor cells in human cord blood.
Xu M; Lu S; Shen B; Li Y
Chin Med J (Engl); 2001 Apr; 114(4):355-9. PubMed ID: 11780453
[TBL] [Abstract][Full Text] [Related]
13. Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxin.
Benedetti G; Bondesan P; Caracciolo D; Cherasco C; Ruggieri D; Gastaldi ME; Pileri A; Gianni AM; Tarella C
Exp Hematol; 1994 Feb; 22(2):166-73. PubMed ID: 7507858
[TBL] [Abstract][Full Text] [Related]
14. Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow.
Uckun FM; Ramakrishnan S; Houston LL
J Immunol; 1985 Mar; 134(3):2010-6. PubMed ID: 3855433
[TBL] [Abstract][Full Text] [Related]
15. Anti-T cell monoclonal antibodies conjugated to ricin as potential reagents for human GVHD prophylaxis: effect on the generation of cytotoxic T cells in both peripheral blood and bone marrow.
Quinones RR; Youle RJ; Kersey JH; Zanjani ED; Azemove SM; Soderling CC; Lebien TW; Beverley PC; Neville DM; Vallera DA
J Immunol; 1984 Feb; 132(2):678-83. PubMed ID: 6606676
[TBL] [Abstract][Full Text] [Related]
16. Abnormal T-lymphocyte colonies (CFU-TL) following bone marrow transplantation.
Mitsuyasu RT; Li SN; Champlin RE; Gale RP
Exp Hematol; 1986 Dec; 14(11):1049-55. PubMed ID: 3536545
[TBL] [Abstract][Full Text] [Related]
17. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts.
Uckun FM; Stong RC; Youle RJ; Vallera DA
J Immunol; 1985 May; 134(5):3504-15. PubMed ID: 3884712
[TBL] [Abstract][Full Text] [Related]
18. Cercopithecus aethiops monkey as a reliable model for in vitro study of T cell depletion of bone marrow with Campath-1 plus complement.
Phan DT; Benczur M; Gidáli J; Fehér I; Harsányi V; Nemes L; Petrányi G; Hollán SR
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):97-106. PubMed ID: 2472335
[TBL] [Abstract][Full Text] [Related]
19. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
20. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.
Bernhard H; Disis ML; Heimfeld S; Hand S; Gralow JR; Cheever MA
Cancer Res; 1995 Mar; 55(5):1099-104. PubMed ID: 7532543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
